JOP20080381B1
(en)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)
|
US8206943B1
(en)
|
2008-06-30 |
2012-06-26 |
Schering Corporation |
Assay for PCSK9 inhibitors
|
US20130064834A1
(en)
|
2008-12-15 |
2013-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia using antibodies to pcsk9
|
JO3672B1
(en)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
High Affinity Human Antibodies to PCSK9
|
MY165159A
(en)
|
2011-01-28 |
2018-02-28 |
Sanofi Biotechnology |
Pharmaceutical compositions comprising human antibodies to pcsk9
|
WO2012177741A1
(en)
*
|
2011-06-20 |
2012-12-27 |
Genentech, Inc. |
Pcsk9-binding polypeptides and methods of use
|
AR087305A1
(en)
|
2011-07-28 |
2014-03-12 |
Regeneron Pharma |
STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES, PREPARATION METHOD AND KIT
|
ES2953713T3
(en)
|
2011-09-16 |
2023-11-15 |
Regeneron Pharma |
Methods to reduce lipoprotein(a) levels by administering a proprotein convertase subtilisin kexin-9 (PCSK9) inhibitor
|
CA2858572C
(en)
|
2011-12-08 |
2023-01-17 |
Amgen Inc. |
Human lcat antigen binding proteins and their use in therapy
|
US9255154B2
(en)
|
2012-05-08 |
2016-02-09 |
Alderbio Holdings, Llc |
Anti-PCSK9 antibodies and use thereof
|
BR112014031310A2
(en)
*
|
2012-06-15 |
2017-07-25 |
Genentech Inc |
anti-pcsk9 antibodies, formulations, dosage and methods of use
|
EA028244B1
(en)
|
2012-08-13 |
2017-10-31 |
Ридженерон Фармасьютикалз, Инк. |
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
|
CA2884887C
(en)
|
2012-11-21 |
2023-09-12 |
Amgen Inc. |
Drug delivery device including insertion member and reservoir
|
EP3593839A1
(en)
|
2013-03-15 |
2020-01-15 |
Amgen Inc. |
Drug cassette
|
US10092703B2
(en)
|
2013-03-15 |
2018-10-09 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
BR112015024282B1
(en)
|
2013-03-22 |
2022-05-17 |
Amgen Inc |
Injector and injector mounting method
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
US10494442B2
(en)
|
2013-06-07 |
2019-12-03 |
Sanofi Biotechnology |
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
|
US20150037816A1
(en)
*
|
2013-08-01 |
2015-02-05 |
Atherotech, Inc. |
PCSK9 Function Assay
|
EP3060281B1
(en)
|
2013-10-24 |
2019-01-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
AU2014340171B2
(en)
|
2013-10-24 |
2019-05-30 |
Amgen Inc. |
Injector and method of assembly
|
CA2929778A1
(en)
|
2013-11-12 |
2015-05-21 |
Sanofi Biotechnology |
Dosing regimens for use with pcsk9 inhibitors
|
US9034332B1
(en)
|
2014-07-15 |
2015-05-19 |
Kymab Limited |
Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
DE202014010499U1
(en)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting of human PCSK9 for cholesterol treatment
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
US9051378B1
(en)
|
2014-07-15 |
2015-06-09 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
US9023359B1
(en)
|
2014-07-15 |
2015-05-05 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
US8986691B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
US8883157B1
(en)
|
2013-12-17 |
2014-11-11 |
Kymab Limited |
Targeting rare human PCSK9 variants for cholesterol treatment
|
US8945560B1
(en)
|
2014-07-15 |
2015-02-03 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
US9045548B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
|
AU2015315834B2
(en)
|
2014-01-31 |
2019-12-12 |
Boehringer Ingelheim International Gmbh |
Novel anti-BAFF antibodies
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
AU2015222283B2
(en)
*
|
2014-02-28 |
2019-11-21 |
Affiris Cvd Gmbh |
PCSK9 vaccines
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
WO2015171777A1
(en)
|
2014-05-07 |
2015-11-12 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
CN106488782B
(en)
|
2014-06-03 |
2021-03-09 |
安姆根有限公司 |
Device and method for assisting a user of a drug delivery device
|
MX2017000527A
(en)
*
|
2014-07-14 |
2017-08-10 |
Amgen Inc |
Crystalline antibody formulations.
|
EP3332790A1
(en)
|
2014-07-15 |
2018-06-13 |
Kymab Limited |
Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
US9150660B1
(en)
|
2014-07-15 |
2015-10-06 |
Kymab Limited |
Precision Medicine by targeting human NAV1.8 variants for treatment of pain
|
DE202015009002U1
(en)
|
2014-07-15 |
2016-08-18 |
Kymab Limited |
Targeting of human PCSK9 for cholesterol treatment
|
WO2016008899A1
(en)
|
2014-07-15 |
2016-01-21 |
Kymab Limited |
Targeting human pcsk9 for cholesterol treatment
|
JP2017528427A
(en)
|
2014-07-16 |
2017-09-28 |
サノフィ・バイオテクノロジー |
Method for treating a patient having heterozygous familial hypercholesterolemia (heFH)
|
WO2016023916A1
(en)
|
2014-08-12 |
2016-02-18 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
AU2015332557B2
(en)
|
2014-10-14 |
2020-05-14 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
WO2016071701A1
(en)
|
2014-11-07 |
2016-05-12 |
Kymab Limited |
Treatment of disease using ligand binding to targets of interest
|
WO2016100055A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
US10583245B2
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
JP2018512184A
(en)
|
2015-02-27 |
2018-05-17 |
アムジエン・インコーポレーテツド |
Drug delivery device having needle guard mechanism capable of adjusting threshold of resistance to movement of needle guard
|
US10772956B2
(en)
|
2015-08-18 |
2020-09-15 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
CN105348390B
(en)
*
|
2015-10-26 |
2018-08-28 |
北京智仁美博生物科技有限公司 |
Anti-human PCSK9 monoclonal antibodies
|
ES2755717T3
(en)
|
2015-12-09 |
2020-04-23 |
Amgen Inc |
Autoinjector with signaling cap
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
ES2814287T3
(en)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reduce the likelihood of glass breakage in drug delivery devices
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
CA3018426A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
JP7275027B2
(en)
|
2016-10-06 |
2023-05-17 |
アムジェン インコーポレイテッド |
Viscosity-lowering protein pharmaceutical formulations
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
WO2018136398A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
WO2018152073A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
MX2019010544A
(en)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Drug delivery device with activation prevention feature.
|
US11571511B2
(en)
|
2017-03-07 |
2023-02-07 |
Amgen Inc. |
Insertion mechanism and method of inserting a needle of a drug delivery device
|
MX2019010671A
(en)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Insertion mechanism for drug delivery device.
|
MX2019011416A
(en)
|
2017-03-28 |
2019-11-01 |
Amgen Inc |
Plunger rod and syringe assembly system and method.
|
BR112019020148A2
(en)
|
2017-04-13 |
2020-05-05 |
Cadila Healthcare Ltd |
peptide
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
MX2019014615A
(en)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Torque driven drug delivery device.
|
AU2018288604B2
(en)
|
2017-06-22 |
2023-12-21 |
Amgen Inc. |
Device activation impact/shock reduction
|
MA49461A
(en)
|
2017-06-23 |
2020-04-29 |
Amgen Inc |
ELECTRONIC DRUG DELIVERY DEVICE INCLUDING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
JP7408398B2
(en)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
Needle insertion and retraction system with dual torsion spring system
|
WO2019018169A1
(en)
|
2017-07-21 |
2019-01-24 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
EP4085942A1
(en)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
JP7242562B2
(en)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
Drug delivery device with container access system and associated method of assembly
|
MA49838A
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
DRUG DELIVERY SYSTEM WITH CHAMBER HYDRAULIC-PNEUMATIC PRESSURE
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
MA50611A
(en)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
FLOW ADAPTER FOR A DRUG DELIVERY DEVICE
|
EP3691716B1
(en)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
EP3694578A1
(en)
|
2017-10-09 |
2020-08-19 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
EP3703778A1
(en)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
System and approaches for sterilizing a drug delivery device
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
JP2021501616A
(en)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
Drug delivery device with placement and flow detection
|
JP7247174B2
(en)
|
2017-11-10 |
2023-03-28 |
アムジエン・インコーポレーテツド |
plunger for drug delivery device
|
CA3084486A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
MX2021000749A
(en)
|
2018-07-24 |
2021-03-29 |
Amgen Inc |
Delivery devices for administering drugs.
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
CN112469454B
(en)
|
2018-07-24 |
2024-01-26 |
安进公司 |
Delivery device for administering a drug
|
MA53320A
(en)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
FLUID PATH ASSEMBLY FOR DRUG DELIVERY DEVICE
|
MA53724A
(en)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
INTERVENTIONAL DOSING SYSTEMS AND METHODS
|
IL281469B1
(en)
|
2018-09-28 |
2024-04-01 |
Amgen Inc |
Muscle wire escapement activation assembly for a drug delivery device
|
AR116679A1
(en)
|
2018-10-02 |
2021-06-02 |
Amgen Inc |
INJECTION SYSTEMS FOR THE ADMINISTRATION OF DRUGS WITH INTERNAL FORCE TRANSMISSION
|
EP3860686A1
(en)
|
2018-10-05 |
2021-08-11 |
Amgen Inc. |
Drug delivery device having dose indicator
|
TW202031306A
(en)
|
2018-10-15 |
2020-09-01 |
美商安進公司 |
Platform assembly process for drug delivery device
|
KR20210076935A
(en)
|
2018-10-15 |
2021-06-24 |
암젠 인크 |
Drug delivery device with damping mechanism
|
WO2020092056A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial needle retraction
|
AU2019370159A1
(en)
|
2018-11-01 |
2021-04-22 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
MA54048A
(en)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
DRUG DELIVERY DEVICES WITH PARTIAL RETRACTION OF DRUG DELIVERY BODY
|
JOP20210193A1
(en)
|
2019-01-18 |
2023-01-30 |
Astrazeneca Ab |
Pcsk9 inhibitors and methods of use thereof
|
JP2022529319A
(en)
|
2019-04-24 |
2022-06-21 |
アムジエン・インコーポレーテツド |
Syringe sterility confirmation assembly and method
|
JP2022545227A
(en)
|
2019-08-23 |
2022-10-26 |
アムジエン・インコーポレーテツド |
Drug delivery device with configurable needle shield-engaging component and related methods
|
WO2022098771A1
(en)
*
|
2020-11-03 |
2022-05-12 |
Ab Studio Inc. |
Multispecific antibodies and uses thereof
|
EP4341161A1
(en)
|
2021-05-21 |
2024-03-27 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|